BARTLETT & CO. WEALTH MANAGEMENT LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 2010186
CINCINNATI, OH
Position in NBIX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$334,214
+$333,728 QoQ
Shares Held
1,983
+39560.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#528
of 768 holders
Holding Since
Dec 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BARTLETT & CO. WEALTH MANAGEMENT LLC holds $1,877,386 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (17.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
16,062 | $1,154,215 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,983 | $334,214 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
20,781 | $333,119 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
594 | $20,124 | |
| 5 | VTRS |
Viatris Inc
|
1,128 | $17,912 | |
| 6 | HLN |
Haleon plc
|
1,097 | $10,235 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
200 | $6,934 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
111 | $498 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $334,214 | 1,983 | Shares | Sole | 2026-07-24 | |
| 2021-06-30 | $486 | 5 | Shares | Sole | 2024-02-14 | |
| 2021-03-31 | $486 | 5 | Shares | Sole | 2024-02-14 | |
| 2020-12-31 | $479 | 5 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||